Morning Briefing
Summaries of health policy coverage from major news organizations
New York Times Examines HIV Prevention Products Undergoing Clinical Trials
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
